Geode Capital Management
EDSA icon

Geode Capital Management’s Edesa Biotech EDSA Stock Holding History

Geode Capital Management’s Portfolio EDSA Stock Details EDSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$658K Buy
80,879
+3,825
+5% +$34.5K ﹤0.01% 3497
2026
Q1 		$403K Buy
77,054
+30,517
+66% +$91.5K ﹤0.01% 3664
2025
Q4 		$67.5K Buy
46,537
+1,303
+3% +$2.55K ﹤0.01% 4181
2025
Q3 		$110K Buy
45,234
+17,278
+62% +$40K ﹤0.01% 4104
2025
Q2 		$56.5K Sell
27,956
-1,014
-4% -$2.16K ﹤0.01% 4189
2025
Q1 		$70.7K Buy
28,970
+9,166
+46% +$19.8K ﹤0.01% 4116
2024
Q4 		$33.7K Sell
19,804
-1,005
-5% -$2.8K ﹤0.01% 4306
2024
Q3 		$92.6K Buy
20,809
+2,590
+14% +$11.8K ﹤0.01% 4125
2024
Q2 		$78.4K Buy
18,219
+3,834
+27% +$17.1K ﹤0.01% 4193
2024
Q1 		$59.7K Sell
14,385
-295
-2% -$1.37K ﹤0.01% 4287
2023
Q4 		$67.4K Sell
14,680
-4
-0% -$15 ﹤0.01% 4280
2023
Q3 		$64.3K Buy
14,684
+2,299
+19% +$13.6K ﹤0.01% 4366
2023
Q2 		$69.4K Hold
12,385
– – ﹤0.01% 4440
2023
Q1 		$79.1K Hold
12,385
– – ﹤0.01% 4412
2022
Q4 		$187K Buy
12,385
+607
+5% +$4.52K ﹤0.01% 4138
2022
Q3 		$75K Hold
11,778
– – ﹤0.01% 4676
2022
Q2 		$131K Buy
11,778
+311
+3% +$4.58K ﹤0.01% 4474
2022
Q1 		$238K Buy
11,467
+431
+4% +$11.9K ﹤0.01% 4291
2021
Q4 		$434K Hold
11,036
– – ﹤0.01% 4124
2021
Q3 		$570K Buy
11,036
+460
+4% +$17.9K ﹤0.01% 3968
2021
Q2 		$390K Buy
10,576
+6,400
+153% +$259K ﹤0.01% 4051
2021
Q1 		$157K Buy
+4,176
New +$168K ﹤0.01% 4189

Other funds holding EDSA

VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management's EDSA Position: Q2 2026 in Review

Geode Capital Management increased its Edesa Biotech (EDSA) stake by 5% in Q2 2026, buying an estimated $34.5K and bringing the position to 80,879 shares worth $658K. The position accounts for ﹤0.01% of the portfolio, ranked #3497.

Geode Capital Management first reported a position in EDSA in Q1 2021 and has held it in 22 quarters since. 33 funds tracked by Wall St. Rank hold EDSA as of Q2 2026.

  • Geode Capital Management held 80,879 shares of Edesa Biotech worth $658K as of Q2 2026.
  • Geode Capital Management bought 3,825 Edesa Biotech shares in Q2 2026, an estimated $34.5K.
  • Edesa Biotech made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #3497 holding.
  • Geode Capital Management first reported a position in Edesa Biotech in Q1 2021 and has held it in 22 quarters since.
  • 33 funds tracked by Wall St. Rank held Edesa Biotech as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.